Matching trials
1,853 results
- EVOGUARDIndependent statistical analysis of Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EVOLVEIndependent statistical analysis of Epanova® for Lowering Very High Triglycerides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01242527).
- EVOLVE-1Independent statistical analysis of the phase 3 EVOLVE-1 trial of galcanezumab for the prevention of episodic migraine, including randomized design, longitudinal mixed-effects analysis, odds ratios, Fisher exact testing, efficacy results, safety, and…
- EVOLVE48Independent statistical analysis of A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- EVOLVEIIIndependent statistical analysis of Epanova® for Lowering Very High Triglycerides II (EVOLVE II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02009865).
- eXalt3Independent statistical analysis of the phase 3 eXalt3 trial comparing ensartinib with crizotinib in ALK-positive non-small cell lung cancer, including trial design, progression-free survival methodology, interpretation, and statistical limitations.
- ExCelA complete statistical analysis of the ExCel phase 3 trial of exemestane for breast cancer prevention in postmenopausal women at increased risk, including trial design, breast cancer-free survival, hazard ratios, confidence intervals,…
- Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03355469).
- Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload: Complete Statistical AnalysisIndependent statistical analysis of Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.: Complete Statistical AnalysisIndependent statistical analysis of Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.: primary endpoint results,…
- EXPEDITEComplete statistical analysis of the EXPEDITE phase 3 trial comparing misoprostol vaginal insert with dinoprostone vaginal insert for reducing time to vaginal delivery during induction of labor.
- ExpeditionPROIndependent statistical analysis of A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EXSCELA detailed independent statistical analysis of EXSCEL, the phase 3 trial of exenatide once weekly versus placebo in patients with type 2 diabetes mellitus, including its randomized design, time-to-event endpoints, Cox models,…
- EXTENDAn independent statistical analysis of the EXTEND phase 3 trial of alteplase versus placebo in stroke, covering its randomized design, 3-month modified Rankin Scale endpoint, planned statistical analysis, and interpretation.
- EXTENDIndependent statistical analysis of Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02725528).
- Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation: Complete Statistical AnalysisIndependent statistical analysis of Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02720536).
- ExteNETIndependent statistical analysis of the phase 3 ExteNET trial of neratinib after adjuvant trastuzumab in women with early stage breast cancer, including randomized design, time-to-event endpoints, hazard ratios, confidence intervals, survival methodology,…
- Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Extension Study of MYL-1701P-3001 for Safety and Efficacy: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of MYL-1701P-3001 for Safety and Efficacy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04674800).
- Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3): Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3): primary endpoint…
- External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FACEIndependent statistical analysis of the FACE phase 3 trial comparing letrozole with anastrozole in the adjuvant treatment of postmenopausal women with hormone receptor and node positive breast cancer.
- FACTComplete statistical analysis of the FACT phase 3 trial of high-dose folic acid supplementation throughout pregnancy for preeclampsia prevention, including randomized trial design, endpoint definitions, risk ratios, confidence intervals, missing-data considerations, and…
- FACT CLBP 1Independent statistical analysis of Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee: primary endpoint results, effect estimate with…
- FACT OA1Complete statistical analysis of the phase 3 FACT OA1 trial of fasinumab versus placebo and naproxen for pain from osteoarthritis of the knee or hip, including trial design, WOMAC endpoints, mixed-effects modeling,…
- FACT OA2Complete statistical analysis of FACT OA2, a randomized phase 3 trial evaluating fasinumab versus placebo and NSAIDs for pain from osteoarthritis of the knee or hip, including endpoint definitions, MMRM and Cochran-Mantel-Haenszel…
- FACTS 001Independent statistical analysis of FACTS 001, a randomized phase 3 trial evaluating tenofovir gel for prevention of HIV-1 infection in women and effects on HSV-2 infection.
- FACTTIndependent statistical analysis of FACTT (NCT00281268), a phase 3 factorial trial evaluating fluid management strategies in acute respiratory distress syndrome.
- FAIR-HFAn independent statistical analysis of the randomized phase 3 FAIR-HF trial evaluating ferric carboxymaltose versus normal saline in patients with chronic heart failure and iron deficiency.
- FAVORITComplete statistical analysis of FAVORIT, a randomized phase 2/3 trial evaluating high-dose versus low-dose multivitamins in kidney transplant recipients with cardiovascular disease risk.
- FEASTIndependent statistical analysis of Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- FEATUREIndependent statistical analysis of A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy: primary endpoint results, effect estimate with confidence…
- FEM-PrEPIndependent statistical analysis of FEM-PrEP, a randomized phase 3 trial evaluating Truvada versus placebo for preventing HIV acquisition in women, including its time-to-event analysis, safety endpoints, secondary outcomes, and statistical interpretation.
- Fenofibrate Treatment in SCI: Complete Statistical AnalysisIndependent statistical analysis of Fenofibrate Treatment in SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02455336).
- Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense: Complete Statistical AnalysisIndependent statistical analysis of Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03974178).
- FIDELIO-DKDIndependent statistical analysis of Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FIGARO UC 303Independent statistical analysis of An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- FIGARO-DKDIndependent statistical analysis of FIGARO-DKD, a randomized phase 3 trial of finerenone versus placebo in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease.
- FIGHT-302Independent statistical analysis of FIGHT-302, a randomized phase 3 trial of pemigatinib versus gemcitabine plus cisplatin in unresectable or metastatic cholangiocarcinoma, including progression-free survival, response, overall survival, statistical methodology, safety, and interpretation.
- FINCH 1Independent statistical analysis of Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate: primary endpoint results, effect estimate with confidence…
- FINEARTS-HFIndependent statistical analysis of FINEARTS-HF, the randomized phase 3 trial evaluating finerenone versus placebo in participants with heart failure and left ventricular ejection fraction greater than or equal to 40%.
- FIRE-3An independent statistical analysis of the FIRE-3 phase 3 randomized trial comparing FOLFIRI plus cetuximab with FOLFIRI plus bevacizumab in first-line colorectal cancer.
- FIREFLEYEIndependent statistical analysis of Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): Complete Statistical AnalysisIndependent statistical analysis of Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…